首页> Scientific reports> Siglec-7 restores β-cell function and survival and reduces inflammation in pancreatic islets from patients with diabetes.

Siglec-7 restores β-cell function and survival and reduces inflammation in pancreatic islets from patients with diabetes.

导出 LinkOut

翻译打印收藏纠错

第一作者： Gitanjali,Dharmadhikari

第一单位： Centre for Biomolecular Interactions Bremen, University of Bremen, Germany.;Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences) and University Medical Center Utrecht, Cancer Genomics Netherlands, Utrecht, The Netherlands.

作者： Gitanjali,Dharmadhikari ^[1] ; Katharina,Stolz ^[2] ; Michael,Hauke ^[2] ; Noel G,Morgan ^[3] ; Ajit,Varki ^[4] ; Eelco,de Koning ^[5] ; Sørge,Kelm ^[2] ; Kathrin,Maedler ^[2]

作者单位： Centre for Biomolecular Interactions Bremen, University of Bremen, Germany.;Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences) and University Medical Center Utrecht, Cancer Genomics Netherlands, Utrecht, The Netherlands. ^[1] Centre for Biomolecular Interactions Bremen, University of Bremen, Germany. ^[2] Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, RILD Building, Barrack Road, Exeter EX2 5DW, UK. ^[3] Glycobiology Research and Training Center and Departments of Medicine and Cellular and Molecular Medicine, University of California at San Diego, La Jolla, CA, USA. ^[4] Hubrecht Institute-KNAW (Royal Netherlands Academy of Arts and Sciences) and University Medical Center Utrecht, Cancer Genomics Netherlands, Utrecht, The Netherlands.;Leiden University Medical Center, Department of Medicine, Section of Nephrology and Section of Endocrinology, Leiden, the Netherlands. ^[5]